gms | German Medical Science

27. Jahrestagung der Deutschen Gesellschaft für Audiologie
und Arbeitstagung der Arbeitsgemeinschaft Deutschsprachiger Audiologen, Neurootologen und Otologen

Deutsche Gesellschaft für Audiologie e. V. und ADANO

19. - 21.03.2025, Göttingen

Article

Send article

First clinical experiences with a sustainable prophylaxis of vestibular migraine by botulinum toxin type A

Meeting Abstract

Search Medline for

  • Rayoung Kim - Univ. HNO-Klinik, Bielefeld, Deutschland
  • Lars-Uwe Scholtz - Univ. HNO-Klinik, Bielefeld, Deutschland
  • presenting/speaker Ingo Todt - Univ. HNO-Klinik, Bielefeld, Deutschland

Deutsche Gesellschaft für Audiologie e. V. und ADANO. 27. Jahrestagung der Deutschen Gesellschaft für Audiologie und Arbeitstagung der Arbeitsgemeinschaft Deutschsprachiger Audiologen, Neurootologen und Otologen. Göttingen, 19.-21.03.2025. Düsseldorf: German Medical Science GMS Publishing House; 2025. Doc091

doi: 10.3205/25dga091, urn:nbn:de:0183-25dga0918

Published: March 18, 2025

© 2025 Kim et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.

Outline

Text

Vestibular migraine is the most frequent vestibular disorder in many neurologic and neurotologic departments. An accepted prophylactic treatment of vestibular migraine is not well established. Although migraine treatment prophylaxis by botulinum toxin is proven and well accepted the effect on vestibular migraine is almost not observed.

This study aimed to evaluate the prophylactic effect of botulinum toxin A on proven vestibular migraine.

Methods: We evaluated 15 patients treated between 2020 and 2024 suffering from vestibular migraine in terms of the effect of botulinum toxin on the prophylaxis of vestibular attacks. Botulinum toxin’s effect was observed at 2 weeks and 3 months after initial individualized injections by DHI and MIDAS questionnaire and compared with the pre-treatment state. Injections were oriented on the Individual migraine pattern.

Results: Botulinum toxin injections led to a significant reduction of migraine and vestibular migraine symptoms in terms of severity and frequency of attacks up to 3 month.

Conclusion: Individualized botulinum toxin injections seem to have a significant prophylactic effect on vestibular migraine.